PAR Equity Snapshot
OSE Weekly Equity Report
OSE Immunotherapeutics SA
What the company does
OSE Immunotherapeutics SA, a clinical-stage biotechnology company, develops immunotherapies in the areas of immune-oncology and immune-inflammation in France and internationally. Its products include Tedopi that is in Phase III clinical trial for the treatment of non-small cell lung cancer, as well as in Phase II clinical trial to pancreatic and ovarian cancer; OSE-279, which is in a Phase I/II clinical trial in patients with advanced solid tumors or lymphomas; OSE-127, a humanized monoclonal antibody that is in Phase II clinical trial for the treatment of ulcerative colitis, as well as Sjögren's Syndrome; and FR104, which …
What the weekly tape is saying
OSE closed the latest completed week at 3.89 EUR. The 4-week return is -28.2% and the 12-week return is 13.1%. Trend Signal is inactive, Market Dynamics is 0.90. Setup signature: Risk-first tape with a 23/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 4.33 EUR
- Vs Trend Line
- -10.1%
- Fair Value
- 5.53 EUR
- Vs Fair Value
- -29.7%
- 52W High
- 7.70 EUR
- 52W Low
- 2.87 EUR
- Drawdown
- -49.5%
- Range Position
- 21.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 5
- 52W Active Breadth
- 9.6%
- Sector Scope
- FR Healthcare
- Sector Rank
- 4 of 76
- Sector Percentile
- 96.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
FR Healthcare
- Tracked Peers
- 76
- 4W Rank
- 71 of 76
- Avg 1W
- -2.1%
- Avg 4W
- -5.9%
- Trend Breadth
- 28.9%
- Positive MD
- 48.7%
FR Biotechnology
- Tracked Peers
- 33
- 4W Rank
- 28 of 33
- Avg 1W
- -2.8%
- Avg 4W
- -11.9%
- Trend Breadth
- 27.3%
- Positive RS
- 21.2%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.90
- 4W MD Change
- 215.9%
- Relative Strength
- -25.08
- 4W RS Change
- -471.7%
- Expectation
- Negative
- Probability
- 40.20%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.5M
- 13W Average
- 1.3M
- 52W Average
- 719.5K
- Vs 13W
- 1.2x
- Vs 52W
- 2.1x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 15.8%
- 52W Volatility
- 9.6%
- Upside Weeks
- 21
- Downside Weeks
- 30
- Downside Breadth
- 57.7%
- Avg Gain / Loss
- 7.9% / -5.7%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- PAR
- Country
- FR
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- EUR
- Market Cap
- 99.5M
Opportunity signals
- Market Dynamics is positive on the latest completed week.
- Latest weekly return ranks in the strongest part of its sector group.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- Recent volatility is running well above the one-year baseline.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 3.89 EUR | 5.3% | 4.33 EUR | 5.53 EUR | 0.90 | -25.08 | 1.5M | Off |
| 5 Jun 2026 | 3.69 EUR | -15.7% | 4.38 EUR | 5.53 EUR | 1.12 | -28.14 | 1.3M | Off |
| 29 May 2026 | 4.38 EUR | -16.9% | 4.44 EUR | 5.53 EUR | 1.12 | -15.22 | 1.3M | Off |
| 22 May 2026 | 5.27 EUR | -2.8% | 4.49 EUR | 5.53 EUR | 1.00 | 2.12 | 2.1M | Off |
| 15 May 2026 | 5.42 EUR | 40.2% | 4.52 EUR | 5.52 EUR | 0.28 | 6.75 | 2.9M | Off |
| 8 May 2026 | 3.87 EUR | 1.1% | 4.54 EUR | 5.51 EUR | -0.33 | -25.50 | 1.1M | Off |
| 1 May 2026 | 3.82 EUR | 26.5% | 4.63 EUR | 5.51 EUR | -0.87 | -26.99 | 3.7M | Off |
| 24 Apr 2026 | 3.02 EUR | -9.1% | 4.73 EUR | 5.51 EUR | -1.34 | -43.24 | 497.0K | Off |
| 17 Apr 2026 | 3.33 EUR | 6.7% | 4.83 EUR | 5.51 EUR | -1.31 | -40.20 | 875.0K | Off |
| 10 Apr 2026 | 3.12 EUR | -5.2% | 4.91 EUR | 5.52 EUR | -1.45 | -43.53 | 406.2K | Off |
| 3 Apr 2026 | 3.29 EUR | 8.3% | 5.00 EUR | 5.53 EUR | -1.38 | -38.87 | 341.1K | Off |
| 27 Mar 2026 | 3.04 EUR | -11.7% | 5.09 EUR | 5.54 EUR | -1.22 | -42.13 | 785.1K | Off |
| 20 Mar 2026 | 3.44 EUR | -6.5% | 5.19 EUR | 5.56 EUR | -1.24 | -34.81 | 435.4K | Off |
| 13 Mar 2026 | 3.68 EUR | -8.4% | 5.29 EUR | 5.57 EUR | -1.25 | -33.05 | 629.0K | Off |